Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04492072 · ClinicalTrials.gov registry record · NA

Misoprostol With Mechanical Dilation Versus Oxytocin With Mechanical Dilation for High-risk Pregnancy Inductions

A NA study of Cesarean Section and High Risk Pregnancy, sponsored by Thomas Jefferson University.

Completed
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT04492072 is a NA study of Cesarean Section and High Risk Pregnancy that has completed, run by Thomas Jefferson University. The registered enrollment target is 150 participants, roughly in line with the 160-participant average among 14 other Cesarean Section trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04492072, a NA study of Cesarean Section and High Risk Pregnancy, has completed, sponsored by Thomas Jefferson University.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to specifically investigate whether oxytocin and mechanical dilation decreases the rate of cesarean section compared to misoprostol and mechanical dilation for pregnancies at risk of fetal compromise

Interventions

  • DRUG Oxytocin
  • DRUG Misoprostol

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University Hospital - Philadelphia

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2020-08-17
Est. Completion 2022-05-26
Phase NA

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT04492072

The ClinicalTrials.gov registry entry for NCT04492072 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 160-participant average among 14 other Cesarean Section trials with a reported enrollment target. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cesarean Section appearing as the primary indexed condition, and to 2 interventions - of which Oxytocin is the first listed.

NCT04492072 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04492072 about?

NCT04492072 is a clinical study titled "Misoprostol With Mechanical Dilation Versus Oxytocin With Mechanical Dilation for High-risk Pregnancy Inductions". The purpose of this study is to specifically investigate whether oxytocin and mechanical dilation decreases the rate of cesarean section compared to misoprostol and mechanical dilation for pregnancies at risk of fetal compromise

What is the current status of trial NCT04492072?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2020-08-17. Estimated completion is 2022-05-26.

What conditions does trial NCT04492072 study?

This clinical trial studies the following conditions: Cesarean Section, High Risk Pregnancy, Oxytocin, Misoprostol.

What interventions are being tested in trial NCT04492072?

The interventions under investigation include: Oxytocin (DRUG), Misoprostol (DRUG).

Who is sponsoring clinical trial NCT04492072?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04492072 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cesarean Section

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.